The Vaccine Injury Compensation Modernization Act of 2026 updates the National Vaccine Injury Compensation Program by increasing compensation awards, extending filing deadlines, streamlining administrative processes, and expanding the list of taxable vaccines to ensure long-term program sustainability.
Lloyd Doggett
Representative
TX-37
The Vaccine Injury Compensation Modernization Act of 2026 updates the National Vaccine Injury Compensation Program by increasing compensation awards, extending the statute of limitations for filing claims, and streamlining administrative processes. The bill also mandates the inclusion of COVID-19 vaccines in the program, expands the list of taxable vaccines, and increases the vaccine excise tax to support program operations. Additionally, it requires the government to develop comprehensive budget plans to address claim backlogs and improve processing efficiency.
Vaccine Injury Program Overhaul: Payout Caps Hit $600,000 as Per-Dose Taxes Triple
The Vaccine Injury Compensation Modernization Act of 2026 is a major legislative tune-up for the federal system that handles claims when someone has a rare, serious reaction to a vaccine. The bill significantly raises the stakes across the board: it doubles the maximum payout for pain and suffering from $250,000 to $600,000, increases the death benefit to that same $600,000 mark (Section 2), and nearly triples the excise tax you pay on every dose from $0.75 to $2.20 (Section 6). Beyond the money, it officially pulls COVID-19 vaccines into this permanent program within 60 days of enactment, moving them out of the temporary emergency system they’ve lived in since the pandemic began.
Bigger Safety Net, Longer Deadlines
If you’ve ever looked into filing a vaccine claim, you know the clock usually runs out fast. This bill stretches the statute of limitations from three years to five years after the first symptom appears (Section 2). For a parent noticing a developmental delay or a worker dealing with a chronic nerve issue, those extra two years provide a much-needed buffer to gather medical records and seek legal advice. The bill also mandates that the 'Special Master' corps—the experts who decide these cases—grow from a maximum of eight people to a minimum of ten. This is a direct attempt to fix the notorious backlog that currently leaves families waiting years for a resolution.
The Cost of Coverage
While the benefits are getting a boost, the bill funds these changes by reaching into the pockets of manufacturers and, ultimately, consumers. By hiking the excise tax to $2.20 per dose and adding new categories like Shingles, RSV, and Dengue vaccines to the taxable list (Section 5), the cost of getting immunized is going up. For a small clinic or a local pharmacy that stocks hundreds of doses, this tax increase represents a significant upfront cost. While the tax is technically paid by manufacturers, history tells us these costs often trickle down to insurance premiums or out-of-pocket fees for those without top-tier coverage.
COVID-19 and the Liability Shift
One of the most significant moves here is the permanent integration of COVID-19 vaccines into the Vaccine Injury Table (Section 3). This means if you are injured by a COVID-19 shot, you no longer have to navigate the more restrictive Countermeasures Injury Compensation Program; you can use the same VICP process as someone who had a reaction to a flu shot. However, the bill keeps a firm grip on legal options. It clarifies that you generally can’t jump straight to a civil lawsuit against a manufacturer if the vaccine was a 'covered countermeasure'—you have to go through the program first. This protects drug makers from massive class-action suits while ensuring there’s a funded pot of money for those who can prove an injury.